Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. A phase 3 trial found that a new meningococcal disease vaccine is ...

Phase-three trials show the NmCV-5 vaccine can illicit an immune response against the five main strains of meningococcal bacteria. Results show immune response from one dose of NmCV-5 was notably ...

An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

Dr. Samba O. Sow, Director General of CVD-Mali, has led efforts to eradicate meningococcal disease in the African Meningitis Belt for more than a decade. University of Maryland School of Medicine ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

In a recent study published in The New England Journal of Medicine, researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine compared to the World Health ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio An investigational pentavalent vaccine ...